Stephen E. Straus
#178,623
Most Influential Person Now
Stephen E. Straus's AcademicInfluence.com Rankings
Stephen E. Strausphilosophy Degrees
Philosophy
#11082
World Rank
#15216
Historical Rank
Logic
#7889
World Rank
#9813
Historical Rank
Download Badge
Philosophy
Stephen E. Straus's Degrees
- Masters Medicine University of Pennsylvania
- Bachelors Biology University of Pennsylvania
Similar Degrees You Can Earn
Why Is Stephen E. Straus Influential?
(Suggest an Edit or Addition)Stephen E. Straus's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. (1998) (684)
- Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. (1999) (562)
- A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. (1999) (481)
- Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. (1999) (458)
- Roles for Endocytosis and Low pH in Herpes Simplex Virus Entry into HeLa and Chinese Hamster Ovary Cells (2003) (355)
- Symptom pathogenesis during acute influenza: Interleukin‐6 and Other cytokine responses (2001) (331)
- Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. (2008) (320)
- Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization. (1987) (318)
- Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. (1988) (246)
- Herpes Simplex Virus Type 1 Enters Human Epidermal Keratinocytes, but Not Neurons, via a pH-Dependent Endocytic Pathway (2005) (233)
- Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. (2009) (230)
- Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes (1994) (212)
- Cellular and Viral Requirements for Rapid Endocytic Entry of Herpes Simplex Virus (2004) (212)
- Recent Advances in Varicella-Zoster Virus Infection (1999) (208)
- Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. (1999) (204)
- Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis. (1976) (189)
- Acyclovir-induced renal failure. Clinical course and histology. (1988) (180)
- A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats (1994) (180)
- Quantitation of Latent Varicella-Zoster Virus and Herpes Simplex Virus Genomes in Human Trigeminal Ganglia (1999) (170)
- Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient. (1984) (139)
- Laser-Capture Microdissection: Refining Estimates of the Quantity and Distribution of Latent Herpes Simplex Virus 1 and Varicella-Zoster Virus DNA in Human Trigeminal Ganglia at the Single-Cell Level (2005) (138)
- Prevention of ultraviolet-light-induced herpes labialis by sunscreen (1991) (131)
- Varicella-zoster virus transcription in human trigeminal ganglia. (1993) (131)
- Comparative biology of latent varicella-zoster virus and herpes simplex virus infections. (1992) (122)
- Structure of varicella-zoster virus DNA (1981) (116)
- Detection and preliminary characterization of herpes simplex virus type 1 transcripts in latently infected human trigeminal ganglia (1988) (112)
- Comparative Efficacy and Immunogenicity of Replication-Defective, Recombinant Glycoprotein, and DNA Vaccines for Herpes Simplex Virus 2 Infections in Mice and Guinea Pigs (2005) (111)
- The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter (1994) (107)
- Rates of Reactivation of Latent Herpes Simplex Virus from Mouse Trigeminal Ganglia Ex Vivo Correlate Directly with Viral Load and Inversely with Number of Infiltrating CD8+ T Cells (2007) (104)
- Gene therapy in the United States: a five-year status report. (1996) (99)
- Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs (1995) (95)
- Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes. (1992) (92)
- Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA (1995) (92)
- Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0 (1992) (91)
- Progressive encephalitis three months after resolution of cutaneous zoster a patient with AIDS (1986) (91)
- Publication of guidelines for the prevention and treatment of B virus infections in exposed persons. (1995) (90)
- Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1 (1988) (81)
- A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain (1993) (81)
- Molecular cloning and physical mapping of varicella-zoster virus DNA. (1982) (80)
- Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity (1987) (79)
- Genome differences among varicella-zoster virus isolates. (1983) (79)
- Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. (1994) (78)
- Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promoters (1993) (76)
- The Quantity of Latent Viral DNA Correlates with the Relative Rates at Which Herpes Simplex Virus Types 1 and 2 Cause Recurrent Genital Herpes Outbreaks (1998) (76)
- Herpes simplex virus infection induces replication of human immunodeficiency virus type 1. (2000) (75)
- Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27 (1994) (74)
- Varicella-zoster virus (VZV) open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNA (1993) (73)
- Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C (1986) (71)
- Genetic Relatedness of Filobasidiella neoformans (Cryptococcus neoformans) and Filobasidiella bacillispora (Cryptococcus bacillisporus) as Determined by Deoxyribonucleic Acid Base Composition and Sequence Homology Studies (1981) (70)
- Specificity and affinity of binding of herpes simplex virus type 2 glycoprotein B to glycosaminoglycans (1997) (70)
- Lack of Interleukin-6 (IL-6) Enhances Susceptibility to Infection but Does Not Alter Latency or Reactivation of Herpes Simplex Virus Type 1 in IL-6 Knockout Mice (1999) (67)
- Varicella-zoster virus gene 63: transcript mapping and regulatory activity. (1995) (66)
- Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine. (1993) (61)
- Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections. (1999) (60)
- Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus. (1988) (57)
- DNA-Minus Temperature-Sensitive Mutants of Adenovirus Type 5 Help Adenovirus-Associated Virus Replication (1976) (55)
- A real‐time PCR assay to identify and discriminate among wild‐type and vaccine strains of varicella‐zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses (2009) (54)
- A controlled seroprevalence survey of primate handlers for evidence of asymptomatic herpes B virus infection. (1995) (52)
- Characterization of herpes simplex virus type 2 latency-associated transcription in human sacral ganglia and in cell culture. (1991) (48)
- Gamma Interferon Impedes the Establishment of Herpes Simplex Virus Type 1 Latent Infection but Has No Impact on Its Maintenance or Reactivation in Mice (2000) (46)
- Varicella-zoster virus glycoproteins E and I expressed in insect cells form a heterodimer that requires the N-terminal domain of glycoprotein I. (1997) (46)
- Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis. (1998) (45)
- Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV. (1996) (44)
- Inversion and circularization of the varicella-zoster virus genome (1985) (44)
- Transcription mapping of the varicella-zoster virus genome (1985) (44)
- Adenine arabinoside 5′‐monophosphate treatment of chronic type B hepatitis (1982) (42)
- The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice. (1999) (40)
- Mutations in the 5' end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes (1997) (39)
- Diverse Herpes Simplex Virus Type 1 Thymidine Kinase Mutants in Individual Human Neurons and Ganglia (2007) (37)
- The nucleotide sequence, 5' end, promoter domain, and kinetics of expression of the gene encoding the herpes simplex virus type 2 latency-associated transcript (1991) (36)
- Cloning and physical mapping of enteric adenoviruses (candidate types 40 and 41) (1984) (35)
- Fine mapping and sequencing of a variable segment in the inverted repeat region of varicella-zoster virus DNA (1985) (34)
- Transcripts of the adenovirus-associated virus genome: multiple polyadenylated RNAs including a potential primary transcript (1980) (34)
- Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B virus Working Group. (1995) (33)
- Detection of varicella‐zoster virus by dot‐blot hybridization using a molecularly cloned viral DNA probe (1984) (33)
- Varicella-Zoster Virus Open Reading Frame 21, Which Is Expressed during Latency, Is Essential for Virus Replication but Dispensable for Establishment of Latency (2003) (32)
- Viral gene expression in rat trigeminal ganglia following neonatal infection with varicella‐zoster virus (1999) (31)
- Detection of enteric adenoviruses by dot‐blot hybridization using a molecularly cloned viral DNA probe (1985) (31)
- Directionality and further mapping of varicella zoster virus transcripts. (1988) (31)
- Early replicative block prevents the efficient growth of fastidious diarrhea‐associated adenoviruses in cell culture (1982) (30)
- Varicella-zoster virus latency. (1991) (30)
- Varicella-zoster virus DNA polymerase and major DNA-binding protein genes have overlapping divergent promoters (1993) (30)
- Mapping of the varicella zoster virus deoxypyrimidine kinase gene and preliminary identification of its transcript. (1986) (30)
- The 2.2-Kilobase Latency-Associated Transcript of Herpes Simplex Virus Type 2 Does Not Modulate Viral Replication, Reactivation, or Establishment of Latency in Transgenic Mice (2001) (29)
- HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element. (1993) (28)
- Overview: The biology of varicella‐zoster virus infection (1994) (28)
- Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation. (1999) (26)
- Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants (1987) (26)
- Herpes simplex virus type 1 transcription is not detectable in quiescent human stromal keratitis by in situ hybridization. (1993) (26)
- Hydrophobic cluster analysis predicts an amino-terminal domain of varicella-zoster virus open reading frame 10 required for transcriptional activation. (1995) (25)
- Quantity of latency-associated transcript produced by herpes simplex virus is not predictive of the frequency of experimental recurrent genital herpes. (1994) (25)
- Treatment of chronic type B hepatitis with multiple ten‐day courses of adenine arabinoside monophosphate (1985) (25)
- Varicella-zoster virus infection of human astrocytes, Schwann cells, and neurons. (1990) (25)
- Extended acyclovir therapy for herpes genitalis: changes in virus sensitivity and strain variation. (1986) (24)
- Down-regulation of glial fibrillary acidic protein expression during acute lytic varicella-zoster virus infection of cultured human astrocytes. (1994) (22)
- Interactions between varicella-zoster virus IE62 and cellular transcription factor USF in the coordinate activation of genes 28 and 29 (1995) (21)
- Structural and kinetic analyses of herpes simplex virus type 1 latency-associated transcripts in human trigeminal ganglia and in cell culture. (1990) (21)
- DNA-binding proteins present in varicella-zoster virus-infected cells (1985) (19)
- Varicella-Zoster Virus: Pathogenesis of latency and reactivation (2000) (18)
- Transfection of KB cells by polyethylene glycol-induced fusion with erythrocyte ghosts containing adenovirus type 2 DNA. (1980) (16)
- DNA hybridization for diagnosis of enteric adenovirus infection from directly spotted human fecal specimens (1987) (16)
- Mechanism of host restriction of adenovirus-associated virus replication in African green monkey kidney cells. (1979) (15)
- Analysis of the promoter and cis-acting elements regulating expression of herpes simplex virus type 2 latency-associated transcripts (1995) (13)
- Distribution of G + C-rich regions in varicella-zoster virus DNA. (1985) (13)
- Baculovirus expression, purification, and properties of varicella-zoster virus gE, gI, and the complex they form. (1998) (11)
- Chronic uveitis in guinea pigs infected with varicella-zoster virus expressing Escherichia coli beta-galactosidase. (1998) (10)
- Transcript mapping and transregulatory behavior of varicella-zoster virus gene 21, a latency-associated gene. (1999) (9)
- Transfection of KB Cells by Liposomes Containing Adenovirus Type 2 DNA (1981) (8)
- The comparative biology of latent herpes simplex virus type 1 and type 2 infections: latency-associated transcript promoter activity and expression in vitro and in infected mice. (1998) (8)
- Chinese Hamster Ovary Cells Herpes Simplex Virus Entry into HeLa and Roles for Endocytosis and Low pH in (2003) (7)
- Fundamental Virology, 4th Edition; and Fields Virology, 4th Edition, Volumes I and II:Fundamental Virology, 4th Edition;Fields Virology, 4th Edition, Volumes I and II (2002) (7)
- Impairment in reactivation of a latency associated transcript (LAT)-deficient HSV-2 is not solely dependent on the latent viral load or the number of CD8(+) T cells infiltrating the ganglia. (2009) (7)
- The uptake, excretion, and radiation hazards of tritiated thymidine in humans. (1977) (6)
- Cell type specific accumulation of the major latency-associated transcript (LAT) of herpes simplex virus type 2 in LAT transgenic mice. (2009) (6)
- Parental adenovirus type 2 genomes recovered early or late in infection possess terminal proteins (1979) (3)
- Department of Health and Human Services, National Institutes of Health, Recombinant DNA Advisory Committee. Minutes of Meeting, December 1-2, 1994 (1995) (2)
- Recombinant DNA Advisory Committee. Minutes of meeting September 12-13, 1994 (1995) (1)
- Structural and Kinetic Analyses of Herpes Simplex Virus Type I Latency-associated Transcripts in Human Trigeminal Ganglia and in Cell Culture (1)
- Clinical Isolate ofHerpesSimplex Virus Type2ThatInduces a Thymidine KinasewithAlteredSubstrate Specificity (1987) (1)
- From molecular biology to medicine (1995) (1)
- Corrigendum to “Cell type specific accumulation of the major latency-associated transcript (LAT) of herpes simplex virus type 2 in LAT transgenic mice” [Virology 386 (2009) 79–87] (2009) (1)
- Laser-Capture Microdissection: Refining Estimates of the Quantity and Distribution of Latent Herpes Simplex Virus 1 and Varicella-Zoster Virus DNA in Human Trigeminal Ganglia at the Single-Cell Level (2005) (0)
- VARICELLA-ZOSTER VIRUS (HERPESVIRIDAE) | General Features (1999) (0)
- Comparative Efficacy and Immunogenicity of Replication-Defective, Recombinant Glycoprotein, and DNA Vaccines for Herpes Simplex Virus 2 Infections in Mice and Guinea Pigs (2005) (0)
- MOLECULAR ANALYSIS OF ACYCLOVIR-RESISTANT VARICELLAZOSTER VIRUS ISOLATES (1987) (0)
- Minutes of the September 9–10, 1993 Recombinant DNA Advisory Committee Meeting (1994) (0)
- in Transgenic Mice Reactivation , or Establishment of Latency Does Not Modulate Viral Replication , Transcript of Herpes Simplex Virus Type 2 The 2 . 2-Kilobase Latency-Associated (2001) (0)
- Inversion andCircularization oftheVaricella-Zoster VirusGenome (1985) (0)
- Genital Herpes Outbreaks Simplex Virus Types 1 and 2 Cause Recurrent with the Relative Rates at Which Herpes The Quantity of Latent Viral DNA Correlates (1998) (0)
- Guinea Pigs Simplex Virus 2 Infections in Mice and Glycoprotein , and DNA Vaccines for Herpes of Replication-Defective , Recombinant Comparative Efficacy and Immunogenicity (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stephen E. Straus?
Stephen E. Straus is affiliated with the following schools:
